Man Group’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.5M | Buy |
148,460
+27,408
| +23% | +$4.16M | 0.04% | 420 |
|
|
2025
Q1 | $18.2M | Buy |
121,052
+38,662
| +47% | +$5.82M | 0.05% | 410 |
|
|
2024
Q4 | $15.2M | Buy |
82,390
+64,456
| +359% | +$11.9M | 0.04% | 484 |
|
|
2024
Q3 | $3.53M | Buy |
17,934
+5,601
| +45% | +$1.1M | 0.01% | 1025 |
|
|
2024
Q2 | $2.55M | Buy |
+12,333
| New | +$2.55M | 0.01% | 1154 |
|
|
2022
Q3 | – | Hold |
0
| – | -$11.3M | – | 2011 |
|
|
2022
Q2 | – | Sell |
-26,613
| Closed | -$7.56M | – | 466 |
|
|
2022
Q1 | $7.56M | Buy |
26,613
+19,383
| +268% | +$5.5M | 0.03% | 721 |
|
|
2021
Q4 | $2.72M | Sell |
7,230
-6,818
| -49% | -$2.57M | 0.01% | 1084 |
|
|
2021
Q3 | $5.8M | Sell |
14,048
-29,531
| -68% | -$12.2M | 0.02% | 775 |
|
|
2021
Q2 | $16.1M | Buy |
43,579
+20,090
| +86% | +$7.43M | 0.06% | 381 |
|
|
2021
Q1 | $6.81M | Sell |
23,489
-33,202
| -59% | -$9.62M | 0.03% | 571 |
|
|
2020
Q4 | $14.2M | Buy |
56,691
+30,249
| +114% | +$7.56M | 0.06% | 319 |
|
|
2020
Q3 | $5.99M | Buy |
26,442
+19,431
| +277% | +$4.4M | 0.02% | 714 |
|
|
2020
Q2 | $1.22M | Sell |
7,011
-34,186
| -83% | -$5.96M | 0.01% | 1212 |
|
|
2020
Q1 | $5.2M | Sell |
41,197
-48,594
| -54% | -$6.13M | 0.03% | 476 |
|
|
2019
Q4 | $13.7M | Buy |
89,791
+65,385
| +268% | +$9.99M | 0.05% | 518 |
|
|
2019
Q3 | $3.23M | Sell |
24,406
-25,561
| -51% | -$3.38M | 0.01% | 1069 |
|
|
2019
Q2 | $7.09M | Sell |
49,967
-47,889
| -49% | -$6.8M | 0.03% | 800 |
|
|
2019
Q1 | $14.2M | Buy |
97,856
+44,645
| +84% | +$6.48M | 0.05% | 427 |
|
|
2018
Q4 | $6.02M | Sell |
53,211
-35,259
| -40% | -$3.99M | 0.03% | 671 |
|
|
2018
Q3 | $11.9M | Buy |
88,470
+16,952
| +24% | +$2.28M | 0.04% | 522 |
|
|
2018
Q2 | $8.03M | Buy |
71,518
+41,776
| +140% | +$4.69M | 0.03% | 687 |
|
|
2018
Q1 | $3.17M | Buy |
+29,742
| New | +$3.17M | 0.01% | 1068 |
|